Bleeding risk in hemodialysis patients

AE van der Sluijs, P Pai, W Zhu, G Ocak - Seminars in Nephrology, 2024 - Elsevier
Cardiovascular diseases are highly prevalent among patients on dialysis. For these
diseases, antiplatelets and antithrombotic therapies including heparin, vitamin K …

Anticoagulation in patients with chronic kidney disease

EJECKT PedroMarques, TA Mavrakanas - Am J Nephrol, 2024 - karger.com
Background: Both atrial fibrillation and venous thromboembolism (VTE) are highly prevalent
among patients with chronic kidney disease (CKD). Until recently, warfarin was the most …

COVID-19 and cardiovascular disease in patients with chronic kidney disease

L Del Vecchio, O Balafa, E Dounousi… - Nephrology Dialysis …, 2024 - academic.oup.com
Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

[HTML][HTML] Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from …

C Becattini, R Bauersachs, G Maraziti, L Bertoletti… - …, 2022 - ncbi.nlm.nih.gov
The effect of renal impairment (RI) on risk of bleeding and recurrent thrombosis in cancer
patients treated with direct oral anticoagulants for venous thromboembolism (VTE) is …

Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review

V Speed, J Czuprynska, JP Patel, R Arya - Research and Practice in …, 2023 - Elsevier
Direct oral anticoagulants (DOACs) have been a welcome addition to clinical practice due to
the practical advantages they confer over traditional anticoagulants. In many countries …

Impacts of Chronic Kidney Disease on Retinal Neurodegeneration: A Cross-Cohort Analysis

X Guo, Z Zhu, G Bulloch, W Huang, W Wang - American Journal of …, 2024 - Elsevier
Purpose To assess the cross-sectional and longitudinal associations between chronic
kidney disease (CKD) and ganglion cell-inner plexiform layer (GCIPL) thickness in a UK …

[HTML][HTML] Venous thromboembolism risk in Asian patients with inflammatory bowel disease: a population-based nationwide inception cohort study

SY Kim, YS Cho, HS Kim, JK Lee, HM Kim, HJ Park… - Gut and liver, 2022 - ncbi.nlm.nih.gov
Methods We performed a population-based cohort study between 2004 and 2015 using
Korean National Health Insurance data. IBD and VTE were defined by ICD-10 codes …

Pulmonary embolism in chronic kidney disease and end-stage renal disease hospitalizations: trends, outcomes, and predictors of mortality in the United States

J Singh, S Khadka, D Solanki, A Kichloo… - SAGE Open …, 2021 - journals.sagepub.com
Background: It is well-known that patients with chronic kidney disease and end-stage renal
disease are at increased risk of pulmonary embolism than patients with normal kidney …

Long-term outcome of chronic thromboembolic pulmonary hypertension in the era where direct oral anticoagulants become available

S Goto, S Goto - Journal of Thrombosis and Haemostasis, 2023 - jthjournal.org
Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease with a poor
prognosis. Indeed, a 3-year mortality rate was reported to be 90% in a series of 49 patients …

The risk of venous thromboembolism after thoracolumbar spine surgery: a population-based cohort study

HW Chen, WT Wu, JH Wang, CL Lin, CY Hsu… - Journal of Clinical …, 2023 - mdpi.com
Background: Although venous thromboembolism (VTE) is rare, including deep vein
thrombosis (DVT) and pulmonary embolism (PE), it is a catastrophic complication after …